The roles of CD73 in modulating tumorigenesis, angiogenesis, and metastasis are increasingly appreciated (7–9) such that it is now recognized as a critical cancer immune checkpoint (IC) non-redundant to PD-1/PD-L1 and CTLA-4 (10–14). Here, NT5E is linked to cancer.